drugset / Trial / NCT02413515

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

NCT02413515

Phase 4 Completed 278 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

To evaluate antihypertensive efficacy and tolerability of Nifedipine GITS 60mg treated for 8 weeks in Chinese hypertensive subjects who failed to achieve BP control with the starting-dose antihypertensive monotherapy.

Timeline

Start
2015-03-26
Primary completion
2016-08-08
Completion
2016-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nifedipine Other / unclassified 60 mg Oral

Indications